173 related articles for article (PubMed ID: 29884479)
21. Laparoscopic distal pancreatectomy for pancreatic ductal adenocarcinoma: Long-term oncologic outcomes after standard resection.
Sahakyan MA; Kim SC; Kleive D; Kazaryan AM; Song KB; Ignjatovic D; Buanes T; Røsok BI; Labori KJ; Edwin B
Surgery; 2017 Oct; 162(4):802-811. PubMed ID: 28756944
[TBL] [Abstract][Full Text] [Related]
22. Neoadjuvant therapy is associated with a reduced lymph node ratio in patients with potentially resectable pancreatic cancer.
Roland CL; Yang AD; Katz MH; Chatterjee D; Wang H; Lin H; Vauthey JN; Pisters PW; Varadhachary GR; Wolff RA; Crane CH; Lee JE; Fleming JB
Ann Surg Oncol; 2015 Apr; 22(4):1168-75. PubMed ID: 25352267
[TBL] [Abstract][Full Text] [Related]
23. The Addition of Postoperative Chemotherapy is Associated with Improved Survival in Patients with Pancreatic Cancer Treated with Preoperative Therapy.
Roland CL; Katz MH; Tzeng CW; Lin H; Varadhachary GR; Shroff R; Javle M; Fogelman D; Wolff RA; Vauthey JN; Crane CH; Lee JE; Fleming JB
Ann Surg Oncol; 2015 Dec; 22 Suppl 3(Suppl 3):S1221-8. PubMed ID: 26350371
[TBL] [Abstract][Full Text] [Related]
24. Preoperative serum CA19-9 and dissected peripancreatic tissue margin as determiners of long-term survival in pancreatic cancer.
Waraya M; Yamashita K; Katagiri H; Ishii K; Takahashi Y; Furuta K; Watanabe M
Ann Surg Oncol; 2009 May; 16(5):1231-40. PubMed ID: 19263172
[TBL] [Abstract][Full Text] [Related]
25. The prognostic influence of intrapancreatic tumor location on survival after resection of pancreatic ductal adenocarcinoma.
Ruess DA; Makowiec F; Chikhladze S; Sick O; Riediger H; Hopt UT; Wittel UA
BMC Surg; 2015 Nov; 15():123. PubMed ID: 26615588
[TBL] [Abstract][Full Text] [Related]
26. Prognostic impact of perioperative serum CA 19-9 levels in patients with resectable pancreatic cancer.
Kondo N; Murakami Y; Uemura K; Hayashidani Y; Sudo T; Hashimoto Y; Nakashima A; Sakabe R; Shigemoto N; Kato Y; Ohge H; Sueda T
Ann Surg Oncol; 2010 Sep; 17(9):2321-9. PubMed ID: 20336387
[TBL] [Abstract][Full Text] [Related]
27. Conditional survival of pancreatic ductal adenocarcinoma in surgical and nonsurgical patients: a retrospective analysis report from a single institution in China.
Liao R; Yang J; Zhou BY; Li DW; Huang P; Luo SQ; Du CY
World J Surg Oncol; 2015 Jun; 13():196. PubMed ID: 26048469
[TBL] [Abstract][Full Text] [Related]
28. Defining and Predicting Early Recurrence in 957 Patients With Resected Pancreatic Ductal Adenocarcinoma.
Groot VP; Gemenetzis G; Blair AB; Rivero-Soto RJ; Yu J; Javed AA; Burkhart RA; Rinkes IHMB; Molenaar IQ; Cameron JL; Weiss MJ; Wolfgang CL; He J
Ann Surg; 2019 Jun; 269(6):1154-1162. PubMed ID: 31082915
[TBL] [Abstract][Full Text] [Related]
29. Serum CA 19-9 response to neoadjuvant therapy is associated with outcome in pancreatic adenocarcinoma.
Boone BA; Steve J; Zenati MS; Hogg ME; Singhi AD; Bartlett DL; Zureikat AH; Bahary N; Zeh HJ
Ann Surg Oncol; 2014 Dec; 21(13):4351-8. PubMed ID: 25092157
[TBL] [Abstract][Full Text] [Related]
30. Serum dickkopf-1 is a novel serological biomarker for the diagnosis and prognosis of pancreatic cancer.
Han SX; Zhou X; Sui X; He CC; Cai MJ; Ma JL; Zhang YY; Zhou CY; Ma CX; Varela-Ramirez A; Zhu Q
Oncotarget; 2015 Aug; 6(23):19907-17. PubMed ID: 26101916
[TBL] [Abstract][Full Text] [Related]
31. The Results of Pancreatic Resections and Long-Term Survival for Pancreatic Ductal Adenocarcinoma: A Single-Institution Experience.
Seppänen H; Juuti A; Mustonen H; Haapamäki C; Nordling S; Carpelan-Holmström M; Sirén J; Luettges J; Haglund C; Kiviluoto T
Scand J Surg; 2017 Mar; 106(1):54-61. PubMed ID: 27130378
[TBL] [Abstract][Full Text] [Related]
32. [Value of combined therapy in pancreatic cancer with a poor prognosis: analysis of 233 clinical cases].
Wang Y; Zhao P; Wang CF; Shan Y; Zhao DB; Tian YT; Sun YM; Che X; Zhang JW
Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(34):2381-5. PubMed ID: 20137689
[TBL] [Abstract][Full Text] [Related]
33. Neoadjuvant therapy for resectable pancreatic ductal adenocarcinoma: The need for patient-centered research.
Cloyd JM; Tsung A; Hays J; Wills CE; Bridges JF
World J Gastroenterol; 2020 Jan; 26(4):375-382. PubMed ID: 32063686
[TBL] [Abstract][Full Text] [Related]
34. [Analysis of factors influencing recurrence and metastasis following curative resection of pancreatic ductal adenocarcinoma].
Xie YB; Zhao P; Wang CF; Shan Y; Zhao DB; Liu Q; Bai XF
Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):686-9. PubMed ID: 19173911
[TBL] [Abstract][Full Text] [Related]
35. NARCA: A novel prognostic scoring system using neutrophil-albumin ratio and Ca19-9 to predict overall survival in palliative pancreatic cancer.
Tingle SJ; Severs GR; Goodfellow M; Moir JA; White SA
J Surg Oncol; 2018 Sep; 118(4):680-686. PubMed ID: 30196571
[TBL] [Abstract][Full Text] [Related]
36. Improvement in treatment and outcome of pancreatic ductal adenocarcinoma in north China.
Chen Y; Hao J; Ma W; Tang Y; Gao C; Hao X
J Gastrointest Surg; 2011 Jun; 15(6):1026-34. PubMed ID: 21484493
[TBL] [Abstract][Full Text] [Related]
37. Prognostic Value of Resection Margin Involvement After Pancreaticoduodenectomy for Ductal Adenocarcinoma: Updates From a French Prospective Multicenter Study.
Delpero JR; Jeune F; Bachellier P; Regenet N; Le Treut YP; Paye F; Carrere N; Sauvanet A; Adham M; Autret A; Poizat F; Turrini O; Boher JM
Ann Surg; 2017 Nov; 266(5):787-796. PubMed ID: 28953554
[TBL] [Abstract][Full Text] [Related]
38. Poorly differentiated resectable pancreatic cancer: is upfront resection worthwhile?
Crippa S; Partelli S; Zamboni G; Barugola G; Capelli P; Inama M; Bassi C; Pederzoli P; Falconi M
Surgery; 2012 Sep; 152(3 Suppl 1):S112-9. PubMed ID: 22766365
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of surgical resection for pancreatic carcinoma at a Japanese single cancer institute.
Nanashima A; Tobinaga S; Abo T; Hatano K; Takeshita H; Nonaka T; Hidaka S; Tanaka K; Kunizaki M; Sawai T; Yasutake T; Nagayasu T
Hepatogastroenterology; 2012 May; 59(115):911-5. PubMed ID: 22469741
[TBL] [Abstract][Full Text] [Related]
40. Inferior head resection of the pancreas for intraductal papillary mucinous neoplasms.
Nakagohri T; Kinoshita T; Konishi M; Takahashi S; Gotohda N; Kobayashi S; Kojima M; Miyauchi H; Asano T
J Hepatobiliary Pancreat Sci; 2010 Nov; 17(6):798-802. PubMed ID: 19727540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
